Xilio Therapeutics, Inc. (Nasdaq:XLO)
Health Care/Life Sciences • Biotechnology
CIK 1840233
Company
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Address
828 Winter Street
Suite 300
Waltham, Massachusetts 02451
828 Winter Street
Suite 300
Waltham, Massachusetts 02451
Employees
89
89
Stock Info
Key Executives
Board Of Directors
Independent Director Yuan J Xu PhD |
Independent Director Daniel Curran MD, MBA |
Independent Director Christina Rossi MBA |
Independent Director Tomas Jan Heyman |
Independent Director Robert W Ross MD |
Independent Director Sara M Bonstein MBA |
SEC filings
Date | Form | Event |
---|---|---|
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
6 Aug, 2024 | 4 | |
31 Jul, 2024 | SC 13G/A | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 8-K | |
17 Jun, 2024 | 3 | |
17 Jun, 2024 | 3 | |
13 Jun, 2024 | 8-K | |
14 May, 2024 | 10-Q | |
14 May, 2024 | 8-K | |
6 May, 2024 | EFFECT | |
3 May, 2024 | 4 | |
3 May, 2024 | 4 | |
3 May, 2024 | 4 | |
3 May, 2024 | 4 | |
2 May, 2024 | UPLOAD | |
2 May, 2024 | CORRESP | |
30 Apr, 2024 | S-3 | |
25 Apr, 2024 | ARS | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | DEFA14A | |
15 Apr, 2024 | 424B5 | |
5 Apr, 2024 | SC 13G | |
5 Apr, 2024 | SC 13G/A | |
3 Apr, 2024 | 3 | |
3 Apr, 2024 | 4 | |
1 Apr, 2024 | 10-K | |
1 Apr, 2024 | 8-K | |
1 Apr, 2024 | S-8 | |
28 Mar, 2024 | 8-K | |
28 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G | |
9 Feb, 2024 | 4 | |
6 Feb, 2024 | SC 13G/A | |
5 Feb, 2024 | SC 13G/A | |
16 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 8-K | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
7 Dec, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
9 Nov, 2023 | 10-K/A | |
9 Nov, 2023 | 10-Q/A | |
9 Nov, 2023 | 10-Q/A | |
3 Nov, 2023 | 8-K | |
7 Sep, 2023 | 3 | |
7 Sep, 2023 | 4 | |
5 Sep, 2023 | 8-K | CEO Change |
18 Aug, 2023 | 4 | |
18 Aug, 2023 | 4 | |
18 Aug, 2023 | 4 | |
18 Aug, 2023 | 4 | |
14 Aug, 2023 | 10-Q | |
14 Aug, 2023 | 8-K | |
7 Aug, 2023 | 4 | |
7 Aug, 2023 | 3 | |
3 Aug, 2023 | 8-K | |
13 Jun, 2023 | 4 | |
13 Jun, 2023 | 4 | |
13 Jun, 2023 | 8-K | |
13 Jun, 2023 | 4 | |
13 Jun, 2023 | 4 | |
13 Jun, 2023 | 4 | |
13 Jun, 2023 | 4 | |
25 May, 2023 | 8-K | |
9 May, 2023 | 10-Q | |
9 May, 2023 | 8-K | |
25 Apr, 2023 | ARS | |
25 Apr, 2023 | DEFA14A | |
25 Apr, 2023 | DEF 14A | |
10 Apr, 2023 | SC 13G | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 3 | |
3 Apr, 2023 | 8-K | |
2 Mar, 2023 | S-8 | |
2 Mar, 2023 | 8-K | |
2 Mar, 2023 | 10-K | |
9 Feb, 2023 | SC 13G/A | |
25 Jan, 2023 | SC 13G | |
9 Jan, 2023 | 8-K | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
29 Dec, 2022 | SC 13G/A | |
23 Dec, 2022 | 8-K | |
18 Nov, 2022 | EFFECT | |
16 Nov, 2022 | 3 | |
16 Nov, 2022 | CORRESP | |
15 Nov, 2022 | UPLOAD | |
14 Nov, 2022 | SC 13G/A | |
9 Nov, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
9 Nov, 2022 | S-3 | |
16 Sep, 2022 | 3 | |
16 Sep, 2022 | 4 | |
15 Sep, 2022 | 8-K | |
9 Aug, 2022 | 10-Q | |
9 Aug, 2022 | 8-K | |
28 Jul, 2022 | 8-K | |
23 Jun, 2022 | 4/A | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 3 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
16 Jun, 2022 | 8-K | |
13 Jun, 2022 | 8-K | |
12 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
26 Apr, 2022 | DEFA14A | |
26 Apr, 2022 | DEF 14A | |
1 Mar, 2022 | 10-K | |
1 Mar, 2022 | 8-K | |
1 Mar, 2022 | S-8 | |
24 Feb, 2022 | 4 | |
24 Feb, 2022 | 4 | |
24 Feb, 2022 | 4 | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | 8-K | |
14 Jan, 2022 | SC 13G | |
6 Jan, 2022 | 3 | |
6 Jan, 2022 | 8-K | |
6 Jan, 2022 | 4 | |
4 Jan, 2022 | 4/A | |
23 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
2 Dec, 2021 | 10-Q | |
2 Dec, 2021 | 8-K | |
5 Nov, 2021 | SC 13D | |
5 Nov, 2021 | SC 13G | |
5 Nov, 2021 | SC 13G | |
5 Nov, 2021 | 3 | |
5 Nov, 2021 | SC 13G | |
4 Nov, 2021 | SC 13G | |
3 Nov, 2021 | 4/A | |
3 Nov, 2021 | SC 13D | |
28 Oct, 2021 | 4 | |
28 Oct, 2021 | 4 | |
28 Oct, 2021 | 4 | |
28 Oct, 2021 | 4 | |
27 Oct, 2021 | SC 13G | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 8-K | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
26 Oct, 2021 | 4 | |
25 Oct, 2021 | 4 | |
25 Oct, 2021 | 4 | |
25 Oct, 2021 | 4 | |
25 Oct, 2021 | 4 | |
25 Oct, 2021 | S-8 | |
22 Oct, 2021 | SEC STAFF | |
22 Oct, 2021 | 3 | |
22 Oct, 2021 | 424B4 | IPO completed |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | EFFECT | |
21 Oct, 2021 | CERT | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
21 Oct, 2021 | 3 | |
20 Oct, 2021 | S-1/A | |
19 Oct, 2021 | CORRESP | |
19 Oct, 2021 | CORRESP | |
18 Oct, 2021 | CORRESP | |
18 Oct, 2021 | S-1/A | |
18 Oct, 2021 | 8-A12B | |
13 Oct, 2021 | UPLOAD | |
1 Oct, 2021 | CORRESP | |
1 Oct, 2021 | S-1 | |
23 Sep, 2021 | UPLOAD | |
14 Sep, 2021 | DRSLTR | |
14 Sep, 2021 | DRS/A | |
25 Jun, 2021 | SEC STAFF | |
21 Jun, 2021 | UPLOAD | |
24 May, 2021 | DRS | |
26 Feb, 2021 | D | |
21 Jan, 2021 | D |
Last update:2024-03-06 13:16:12.294600
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.